Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

J Donate-Correa, MD Sanchez-Niño… - Clinical Kidney …, 2022 - academic.oup.com
Diabetic kidney disease is one of the most frequent complications in patients with diabetes
and constitutes a major cause of end-stage kidney disease. The prevalence of diabetic …

Preoperative Assessment of Patients with Vascular Disease

RJ Beaulieu - Surgical Clinics, 2023 - surgical.theclinics.com
Patients with vascular disease often have a complex list of comorbid conditions that affect
both their presentation and treatment. Highly prevalent conditions such as atherosclerosis …

[HTML][HTML] Association Between Pentoxifylline Use and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Multi-Institutional …

TY Lin, EYC Kang, NK Wang, JH Kang, KJ Chen… - Biomedical Journal, 2024 - Elsevier
Background Pentoxifylline is administrated to improve the hemodynamics of patients with
chronic kidney disease (CKD). Despite the improvement of capillary blood flow velocity in …

Immunomodulatory and Antioxidant Effects of Pentoxifylline and Other Therapeutic Agents in The Management of Myocardial Injury

A Saeed, N Sabri, MA Saleh… - … Sciences Ain Shams …, 2023 - aps.journals.ekb.eg
Background: Myocardial injury, particularly during myocardial infarction (MI), triggers an
inflammatory response that is crucial for starting the myocardial healing process but is also …

[HTML][HTML] Continuing Education Activity

P Annamaraju, KM Baradhi - europepmc.org
Pentoxifylline Pavan Annamaraju; Preeti Patel; Krishna M. Baradhi. Author Information Last
Update: February 29, 2024. Continuing Education Activity Pentoxifylline is a xanthine …